Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In studies of injured tendons, ligaments, and skeletal muscle, BPC-157 has been associated with faster repair and improved tissue integrity during healing
CJC-1295: Head-to-Head Comparison | Feature | Sermorelin | CJC-1295 (no DAC) | CJC-1295 (with DAC) | |---|---|---|---| | Amino acid length | 29 | 29 (modified) | 29 (modified + albumin-binding) | | Half-life | ~10-20 min | ~30 min | ~6-8 days | | GH release pattern | Pulsatile | Pulsatile | Sustained (blunted pulsatility) | | FDA approval | Withdrawn 2008 | Never approved | Never approved | | Injection frequency | Daily (bedtime) | 1-3x daily | Once weekly | | IGF-1 rise (trial data) | ~30% (Corpas et al.) | Not isolated in RCT | ~2-10x GH (Jett et al.) | | Evidence level | Small RCT | Pharmacokinetic data | Phase II PK study | Frequently Asked Questions Frequently asked questions Can you combine Sermorelin and CJC-1295
3 Treatment effects in the semaglutide 0.4 mg group versus the placebo group at weeks 28, 52 and 72 for each of the four SomaSignal NASH tests
Gordan et al
